ID

22666

Beschreibung

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00600587

Link

https://clinicaltrials.gov/show/NCT00600587

Stichworte

  1. 09.06.17 09.06.17 -
Hochgeladen am

9. Juni 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Carcinoma, Non-Small-Cell Lung NCT00600587

Eligibility Carcinoma, Non-Small-Cell Lung NCT00600587

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent
Beschreibung

ID.1

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
histological or cytological documented
Beschreibung

ID.2

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0449575
UMLS CUI [1,2]
C0205471
UMLS CUI [1,3]
C0007131
resectable nsclc of stage iiia-n2 confirmed by mediastinoscopy or pet
Beschreibung

ID.3

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C1300072
naive therapy nsclc
Beschreibung

ID.4

Datentyp

boolean

Alias
UMLS CUI [1]
C0919936
candidates should be tolerated with induction therapy and thoracotomy with ecog performance status 0-2, adequate haematological and hepatic- renal function and qualified lung function
Beschreibung

ID.5

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1520224
UMLS CUI [1,2]
C0678852
UMLS CUI [1,3]
C0857127
enough tissue samples to perform gene analysis
Beschreibung

ID.6

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3267141
UMLS CUI [1,2]
C0475358
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
small cell lung cancer
Beschreibung

ID.7

Datentyp

boolean

Alias
UMLS CUI [1]
C0149925
pregnant or breast-feeding women
Beschreibung

ID.8

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0549206
UMLS CUI [1,2]
C0006147
any unstable systemic disease
Beschreibung

ID.9

Datentyp

boolean

Alias
UMLS CUI [1]
C1385002
patients with exposure to investigational drug therapy or other concurrent anticancer therapy outside of this trial
Beschreibung

ID.10

Datentyp

boolean

Alias
UMLS CUI [1]
C0008976

Ähnliche Modelle

Eligibility Carcinoma, Non-Small-Cell Lung NCT00600587

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
ID.2
Item
histological or cytological documented
boolean
C0449575 (UMLS CUI [1,1])
C0205471 (UMLS CUI [1,2])
C0007131 (UMLS CUI [1,3])
ID.3
Item
resectable nsclc of stage iiia-n2 confirmed by mediastinoscopy or pet
boolean
C0007131 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
ID.4
Item
naive therapy nsclc
boolean
C0919936 (UMLS CUI [1])
ID.5
Item
candidates should be tolerated with induction therapy and thoracotomy with ecog performance status 0-2, adequate haematological and hepatic- renal function and qualified lung function
boolean
C1520224 (UMLS CUI [1,1])
C0678852 (UMLS CUI [1,2])
C0857127 (UMLS CUI [1,3])
ID.6
Item
enough tissue samples to perform gene analysis
boolean
C3267141 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
ID.7
Item
small cell lung cancer
boolean
C0149925 (UMLS CUI [1])
ID.8
Item
pregnant or breast-feeding women
boolean
C0549206 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
ID.9
Item
any unstable systemic disease
boolean
C1385002 (UMLS CUI [1])
ID.10
Item
patients with exposure to investigational drug therapy or other concurrent anticancer therapy outside of this trial
boolean
C0008976 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video